Strategic growth Potential upsell through integration of ready-to-use implants and instruments with additional spine and hip surgery devices from larger surgical OEMs, leveraging Safe Orthopaedics' acquisition history to expand market reach.

Operational efficiency Highlight value in streamlined OR workflow, radiolucent, contamination-free instruments to drive cost savings and faster turnover for hospitals and ambulatory surgery centers, creating a compelling ROI narrative.

Global expansion With a modest revenue base and recent M&A activity, pursue partnerships or distributor arrangements in new geographies to accelerate adoption among mid-size to large spine and orthopedic manufacturers.

Quality and safety Position as a safety-forward supplier emphasizing infection risk reduction and visibility benefits to meet stringent hospital procurement criteria, aligning with sustainability and patient safety goals.

Strategic partnerships Target collaborations with mid-cap medical device firms of a similar scale to extend product offerings, leverage complementary portfolios, and co-market ready-to-use instrumentation solutions.